Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
Trevisi L, Hernán MA, Mitnick CD, Khan U, Seung KJ, Rich ML, Bastard M, Huerga H, Melikyan N, Atwood SA, Avaliani Z, Llanos F, Manzur-Ul-Alam M, Zarli K, Binegdie AB, Adnan S, Melikyan A, Gelin A, Isani AK, Vetushko D, Daugarina Z, Nkundanyirazo P, Putri FA, Vilbrun C, Khan M, Hewison C, Khan PY, Franke MF. Trevisi L, et al. Among authors: avaliani z. Am J Respir Crit Care Med. 2023 Jun 1;207(11):1525-1532. doi: 10.1164/rccm.202211-2125OC. Am J Respir Crit Care Med. 2023. PMID: 36802336 Free PMC article. Clinical Trial.
Is 6 months of bedaquiline enough? Results from the compassionate use of bedaquiline in Armenia and Georgia.
Hewison C, Bastard M, Khachatryan N, Kotrikadze T, Hayrapetyan A, Avaliani Z, Kiria N, Yegiazaryan L, Chumburidze N, Kirakosyan O, Atshemyan H, Qayyum S, Lachenal N, Varaine F, Huerga H. Hewison C, et al. Among authors: avaliani z. Int J Tuberc Lung Dis. 2018 Jul 1;22(7):766-772. doi: 10.5588/ijtld.17.0840. Int J Tuberc Lung Dis. 2018. PMID: 29914602
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis.
Mbuagbaw L, Guglielmetti L, Hewison C, Bakare N, Bastard M, Caumes E, Fréchet-Jachym M, Robert J, Veziris N, Khachatryan N, Kotrikadze T, Hayrapetyan A, Avaliani Z, Schünemann HJ, Lienhardt C. Mbuagbaw L, et al. Among authors: avaliani z. Emerg Infect Dis. 2019 May;25(5):936-943. doi: 10.3201/eid2505.181823. Emerg Infect Dis. 2019. PMID: 31002070 Free PMC article.
Lung Tissue Concentrations of Pyrazinamide among Patients with Drug-Resistant Pulmonary Tuberculosis.
Kempker RR, Heinrichs MT, Nikolaishvili K, Sabulua I, Bablishvili N, Gogishvili S, Avaliani Z, Tukvadze N, Little B, Bernheim A, Read TD, Guarner J, Derendorf H, Peloquin CA, Blumberg HM, Vashakidze S. Kempker RR, et al. Among authors: avaliani z. Antimicrob Agents Chemother. 2017 May 24;61(6):e00226-17. doi: 10.1128/AAC.00226-17. Print 2017 Jun. Antimicrob Agents Chemother. 2017. PMID: 28373198 Free PMC article.
A comparison of linezolid lung tissue concentrations among patients with drug-resistant tuberculosis.
Kempker RR, Heinrichs MT, Nikolaishvili K, Sabulua I, Bablishvili N, Gogishvili S, Avaliani Z, Little BP, Bernheim A, Derendorf H, Blumberg HM, Vashakidze S, Peloquin CA. Kempker RR, et al. Among authors: avaliani z. Eur Respir J. 2018 Feb 7;51(2):1702166. doi: 10.1183/13993003.02166-2017. Print 2018 Feb. Eur Respir J. 2018. PMID: 29437945 Free PMC article. No abstract available.
49 results